Nile Alternatives & Competitors
12 companies similar to Nile — Replacing Trying with Knowing in Epilepsy Care
MindMaze Therapeutics
Accelerating humanity’s ability to recover, learn and adapt through advanced neuroscience...
Sudo Biosciences
Developing precision TYK2 therapeutics.
Clarity
Make brain health accessible to everyone, everywhere.
Biopharmaceutical Research Company
Developing the Next Generation of Cannabinoid Therapeutics
Track all Nile competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegene...
ACTIMED THERAPEUTICS
Innovation in Cachexia
Pine Park Health
Exceptional primary care for residents of senior living communities.
medbo KU
medbo überraschend anders
Lophora
Developing Next Generation Neuroactive Medicines to Treat Mental Illness
UCB
We’re #TeamUCB, a global biopharmaceutical company. 💙 Inspired by patients 🔬 Driven by s...
AiiNTENSE
Plateforme clinique et d'innovation en neurologie et en réanimation
Sukino Continuum Care
Sukino is leading Continuum Care Provider in India providing post-operative Rehab, Palliat...
About Nile
Replacing Trying with Knowing in Epilepsy Care
Machine learning-based neurological care platform connecting patients with their care teams for personalized treatment
Patients living with neurological conditions (Epilepsy, ADHD, Dementia), caregivers, and physicians
Data-driven Care, Digital Health, Epilepsy Care Management, Personalized Care, Patient Engagement
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Nile and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Nile on 11 Jun 2025. The 12 companies listed here were last checked between 11 Jun 2025 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.